Semaphorin7A promotes tumor growth and exerts a pro-angiogenic effect in macrophages of mammary tumor-bearing mice

Frontiers in Physiology

Volumn 5 FEB, Issue , 2014, Pages

  Garcia Areas, Ramon ^a   Libreros, Stephania ^a   Amat, Samantha ^a   Keating, Patricia ^b   Carrio, Roberto ^c   Robinson, Phillip ^a   Blieden, Clifford ^d   Iragavarapu Charyulu, Vijaya ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

^b FLORIDA ATLANTIC UNIVERSITY   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d JACKSON MEMORIAL HOSPITAL   (United States)

Author keywords

Angiogenesis; Breast cancer; CXCL2 MIP 2; Macrophages; MMP 9; SEMA7A

Indexed keywords

BETA1 INTEGRIN; CXCL2 CHEMOKINE; GELATINASE B; SEMAPHORIN; VASCULOTROPIN A; VASCULOTROPIN B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CARCINOGENESIS; CELL MIGRATION; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; GENE SILENCING; GROWTH INHIBITION; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; ONCOGENE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SEMA7A GENE; TUMOR GROWTH; UPREGULATION;

EID: 84895441558     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00017     Document Type: Article

References (53)

1. Acevedo, L. M., Barillas, S., Weis, S. M., Gothert, J. R., and Cheresh, D. A. (2008). Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Blood 111, 2674-2680. doi: 10.1182/blood-2007-08-110205.
2. Banu, N., Teichman, J., Dunlap-Brown, M., Villegas, G., and Tufro, A. (2006). Semaphorin 3C regulates endothelial cell function by increasing integrin activity. FASEB J. 20, 2150-2152. doi: 10.1096/fj.05-5698fje.
3. Basile, J. R., Barac, A., Zhu, T., Guan, K. L., and Gutkind, J. S. (2004). Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res. 64, 5212-5224. doi: 10.1158/0008-5472.CAN-04-0126.
4. Basile, J. R., Castilho, R. M., Williams, V. P., and Gutkind, J. S. (2006). Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 103, 9017-9022. doi: 10.1073/pnas.0508825103.
5. Casazza, A., Fu, X., Johansson, I., Capparuccia, L., Andersson, F., Giustacchini, A., et al. (2011). Systemic and targeted delivery of semaphorin 3A inhibits tumor angiogenesis and progression in mouse tumor models. Arterioscler. Thromb. Vasc. Biol. 31, 741-749. doi: 10.1161/ATVBAHA.110.211920.
6. Capparuccia, L., and Tamagnone, L. (2009). Semaphorin signaling in cancer cells and in cells of the tumor microenvironment-two sides of a coin. J. Cell Sci. 122, 1723-1736. doi: 10.1242/jcs.030197.
7. Comeau, M. R., Johnson, R., DuBose, R. F., Petersen, M., Gearing, P., VandenBos, T., et al. (1998). A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR. Immunity 8, 473-482. doi: 10.1016/S1074-7613(00)80552-X.
8. Delorme, G., Saltel, F., Bonnelye, E., Jurdic, P., and Machuca-Gayet, I. (2005). Expression and function of semaphorin 7A in bone cells. Biol. Cell 97, 589-597. doi: 10.1042/BC20040103.
9. DiNapoli, M. R., Calderon, C. L., and Lopez, D. M. (1997). Phosphatidyl serine is involved in the reduced rate of transcription of the inducible nitric oxide synthase gene in macrophages from tumor-bearing mice. J. Immunol. 158, 1810-1817.
10. Filleur, S., Nelius, T., de Riese, W., and Kennedy, R. C. (2009). Characterization of PEDF: a multi-functional serpin family protein. J. Cell Biochem. 106, 769-775. doi: 10.1002/jcb.22072.
11. Folkman, J. (1971). Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182-1186. doi: 10.1056/NEJM197111182852108.
12. Fong, K. P., Barry, C., Tran, A. N., Traxler, E. A., Wannemacher, K. M., Tang, H. Y., et al. (2011). Deciphering the human platelet sheddome. Blood 117, e15-e26. doi: 10.1182/blood-2010-05-283838.
13. Formolo, C. A., Williams, R., Gordish-Dressman, H., MacDonald, T. J., Lee, N. H., and Hathout, Y. (2011). Secretome signature of invasive glioblastoma multiforme. J. Proteome Res. 10, 3149-3159. doi: 10.1021/pr200210w.
14. Gan, Y., Reilkoff, R., Peng, X., Russell, T., Chen, Q., Mathai, S. K., et al. (2011). Role of semaphorin 7a signaling in transforming growth factor beta1-induced lung fibrosis and scleroderma-related interstitial lung disease. Arthritis Rheum. 63, 2484-2494. doi: 10.1002/art.30386.
15. Ghanem, R. C., Han, K. Y., Rojas, J., Ozturk, O., Kim, D. J., Jain, S., et al. (2011). Semaphorin 7A promotes angiogenesis in an experimental corneal neovascularization model. Curr. Eye Res. 36, 989-996. doi: 10.3109/02713683.2011.593730.
16. Guo, W., and Giancotti, F. G. (2004). Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol. 5, 816-826. doi: 10.1038/nrm1490.
17. Guttmann-Raviv, N., Shraga-Heled, N., Varshavsky, A., Guimaraes-Sternberg, C., Kessler, O., and Neufeld, G. (2007). Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J. Biol. Chem. 282, 26294-26305. doi: 10.1074/jbc.M609711200.
18. Handel-Fernandez, M. E., Cheng, X., Herbert, L. M., and Lopez, D. M. (1997). Down-regulation of IL-12, not a shift from a T helper-1 to a T helper-2 phenotype, is responsible for impaired IFN-gamma production in mammary tumor-bearing mice. J. Immunol. 158, 280-286.
19. Harburg, G. C., and Hinck, L. (2011). Navigating breast cancer: axon guidance molecules as breast cancer tumor suppressors and oncogenes. J. Mamm. Gland Biol. Neoplasia 16, 257-270. doi: 10.1007/s10911-011-9225-1.
20. Henningsen, J., Rigbolt, K. T., Blagoev, B., Pedersen, B. K., and Kratchmarova, I. (2010). Dynamics of the skeletal muscle secretome during myoblast differentiation. Mol. Cell Proteomics 9, 2482-2496. doi: 10.1074/mcp.M110.002113.
21. Holmes, S., Downs, A. M., Fosberry, A., Hayes, P. D., Michalovich, D., Murdoch, P., et al. (2002). Sema7A is a potent monocyte stimulator. Scand. J. Immunol. 56, 270-275. doi: 10.1046/j.1365-3083.2002.01129.x.
22. Holvoet, S., Vincent, C., Schmitt, D., and Serres, M. (2003). The inhibition of MAPK pathway is correlated with down-regulation of MMP-9 secretion induced by TNF-alpha in human keratinocytes. Exp. Cell Res. 290, 108-119. doi: 10.1016/S0014-4827(03)00293-3.
23. Kang, H. R., Lee, C. G., Homer, R. J., and Elias, J. A. (2007). Semaphorin 7A plays a critical role in TGF-beta1-induced pulmonary fibrosis. J. Exp. Med. 204, 1083-1093. doi: 10.1084/jem.20061273.
24. Kikutani, H., Suzuki, K., and Kumanogoh, A. (2007). Immune semaphorins: increasing members and their diverse roles. Adv. Immunol. 93, 121-143. doi: 10.1016/S0065-2776(06)93003-X.
25. Koppel, A. M., Feiner, L., Kobayashi, H., and Raper, J. A. (1997). A 70 amino acid region within the semaphorin domain activates specific cellular response of semaphorin family members. Neuron 19, 531-537. doi: 10.1016/S0896-6273(00)80369-4.
26. Kumanogoh, A., and Kikutani, H. (2003). Immune semaphorins: a new area of semaphorin research. J. Cell Sci. 116, 3463-3470. doi: 10.1242/jcs.00674.
27. Lam, D., Harris, D., and Qin, Z. (2013). Inflammatory mediator profiling reveals immune properties of chemotactic gradients and macrophage mediator production inhibition during thioglycollate elicited peritoneal inflammation. Mediat. Inflamm. 2013, 931562. doi: 10.1155/2013/931562.
28. Lange, C., Liehr, T., Goen, M., Gebhart, E., Fleckenstein, B., and Ensser, A. (1998). New eukaryotic semaphorins with close homology to semaphorins of DNA viruses. Genomics 51, 340-350. doi: 10.1006/geno.1998.5256.
29. Libreros, S., Garcia-Areas, R., Shibata, Y., Carrio, R., Torroella-Kouri, M., and Iragavarapu-Charyulu, V. (2012). Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: decreased tumor metastasis in a breast cancer model. Int. J. Cancer. 131, 377-386. doi: 10.1002/ijc.26379.
30. Lopez, D. M., Handel-Fernandez, M. E., Cheng, X., Charyulu, V., Herbert, L. M., DiNapoli, M. R., et al. (1996). Cytokine production by lymphoreticular cells from mammary tumor bearing mice: the role of tumor-derived factors. Anticancer Res. 16, 3923-3929.
31. Lopez, D. M., Lopez-Cepero, M., Watson, G. A., Ganju, A., Sotomayor, E., and Fu, Y. X. (1991). Modulation of the immune system by mammary tumor-derived factors. Cancer Invest. 9, 643-653. doi: 10.3109/07357909109039876.
32. Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., and Ruco, L. (1992). The origin and function of tumor-associated macrophages. Immunol. Today 13, 265-270. doi: 10.1016/0167-5699(92)90008-U.
33. Meda, C., Molla, F., De Pizzol, M., Regano, D., Maione, F., Capano, S., et al. (2012). Semaphorin 4A exerts a proangiogenic effect by enhancing vascular endothelial growth factor-A expression in macrophages. J. Immunol. 188, 4081-4092. doi: 10.4049/jimmunol.1101435.
34. Melnicoff, M. J., Horan, P. K., and Morahan, P. S. (1989). Kinetics of changes in peritoneal cell populations following acute inflammation. Cell Immunol. 118, 178-191. doi: 10.1016/0008-8749(89)90367-5.
35. Moon, S. K., Cha, B. Y., and Kim, C. H. (2004). ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: involvement of the ras dependent pathway. J. Cell Physiol. 198, 417-427. doi: 10.1002/jcp.10435.
36. Nishiyama, A., Shinohara, T., Pantuso, T., Tsuji, S., Yamashita, M., Shinohara, S., et al. (2008). Depletion of cellular cholesterol enhances macrophage MAPK activation by chitin microparticles but not by heat-killed Mycobacterium bovis BCG. Am. J. Physiol. Cell Physiol. 295, C341-C349. doi: 10.1152/ajpcell.00446.2007.
37. Nishiyama, A., Tsuji, S., Yamashita, M., Henriksen, R. A., Myrvik, Q. N., and Shibata, Y. (2006). Phagocytosis of N-acetyl-D-glucosamine particles, a Th1 adjuvant, by RAW 264.7 cells results in MAPK activation and TNF-alpha, but not IL-10, production. Cell Immunol. 239, 103-112. doi: 10.1016/j.cellimm.2006.04.003.
38. Owen, J. L., Criscitiello, M. F., Libreros, S., Garcia-Areas, R., Guthrie, K., Torroella-Kouri, M., et al. (2011). Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1-3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice. Cell Immunol. 270, 172-182. doi: 10.1016/j.cellimm.2011.05.004.
39. Owen, J. L., Iragavarapu-Charyulu, V., Gunja-Smith, Z., Herbert, L. M., Grosso, J. F., and Lopez, D. M. (2003). Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor. J. Immunol. 171, 4340-4351.
40. Pasterkamp, R. J., and Kolodkin, A. L. (2003). Semaphorin junction: making tracks toward neural connectivity. Curr. Opin. Neurobiol. 13, 79-89. doi: 10.1016/S0959-4388(03)00003-5.
41. Pasterkamp, R. J., Peschon, J. J., Spriggs, M. K., and Kolodkin, A. L. (2003). Semaphorin 7A promotes axon outgrowth through integrins and MAPKs. Nature 424, 398-405. doi: 10.1038/nature01790.
42. Pollard, J. W. (2004). Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4, 71-78. doi: 10.1038/nrc1256.
43. Sadanandam, A., Rosenbaugh, E. G., Singh, S., Varney, M., and Singh, R. K. (2010). Semaphorin 5A promotes angiogenesis by increasing endothelial cell proliferation, migration, and decreasing apoptosis. Microvasc. Res. 79, 1-9. doi: 10.1016/j.mvr.2009.10.005.
44. Sakurai, A., Gavard, J., Annas-Linhares, Y., Basile, J. R., Amornphimoltham, P., Palmby, T. R., et al. (2010). Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras. Mol. Cell Biol. 30, 3086-3098. doi: 10.1128/MCB.01652-09.
45. Sierra, J. R., Corso, S., Caione, L., Cepero, V., Conrotto, P., Cignetti, A., et al. (2008). Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. J. Exp. Med. 205, 1673-1685. doi: 10.1084/jem.20072602.
46. Sotomayor, E. M., Fu, Y. X., Lopez-Cepero, M., Herbert, L., Jimenez, J. J., Albarracin, C., et al. (1991). Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor. J. Immunol. 147, 2816-2823.
47. Suzuki, K., Okuno, T., Yamamoto, M., Pasterkamp, R. J., Takegahara, N., Takamatsu, H., et al. (2007). Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin. Nature 446, 680-684. doi: 10.1038/nature05652.
48. Torroella-Kouri, M., Keith, J. C., Ivanova, M., and Lopez, D. M. (2003). IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice. Int. J. Oncol. 22, 439-448.
49. Varshavsky, A., Kessler, O., Abramovitch, S., Kigel, B., Zaffryar, S., Akiri, G., et al. (2008). Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases. Cancer Res. 68, 6922-6931. doi: 10.1158/0008-5472.CAN-07-5408.
50. Xu, X., Ng, S., Wu, Z. L., Nguyen, D., Homburger, S., Seidel-Dugan, C., et al. (1998). Human semaphorin K1 is glycosylphosphatidylinositol-linked and defines a new subfamily of viral-related semaphorins. J. Biol. Chem. 273, 22428-22434. doi: 10.1074/jbc.273.35.22428.
51. Yao, E. S., Zhang, H., Chen, Y. Y., Lee, B., Chew, K., Moore, D., et al. (2007). Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res. 67, 659-664. doi: 10.1158/0008-5472.CAN-06-2768.
52. Zhang, X., Goncalves, R., and Mosser, D. M. (2008). The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. Chapter 14, Unit 14.1. doi: 10.1002/0471142735.im1401s83.
53. Zhou, Y., Gunput, R. A., and Pasterkamp, R. J. (2008). Semaphorin signaling: progress made and promises ahead. Trends Biochem Sci. 33, 161-170. doi: 10.1016/j.tibs.2008.01.006.